Big Pharma-backed Aktis Oncology has announced plans to go public, in the latest encouraging sign for those betting on a ...

Clinical data presented at ASCO 2025 showed an objective response rate (ORR) of 63% among all patients, with a median progression-free survival (PFS) of 7.7 months. Responses were seen across ...

Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Matsue is a city shaped by water, stories and shadow, where ancient Izumo history, folklore, crafts and daily life quietly ...

It’s safe to say that at the end of its eight-episode first season, Prime Video and the Westworld team of Jonathan Nolan and Lisa Joy have seemingly pulled off the impossible and successfully adapted ...

Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Vikki Velasquez is a researcher and writer who has managed, coordinated, ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...